Uterine Cancer clinical trials

Explore recruiting uterine cancer clinical trials.

Recruiting uterine cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Uterine Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Neo-Adjuvant Pembrolizumab as an alternative treatment for MMRd uterine cancer, a phase II efficacy study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

SENtinel lymph node mapping with GAllium-68-tilmanocept PET/CT in high/high- intermediate risk endometrial cancer: a proof-of-concept study

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, randomized, multi-site, open-label trial of BNT323/DB-1303 versus investigator’s choice of chemotherapy in previously treated patients with HER2- expressing recurrent endometrial cancer

Denmark, Poland, Italy, Finland, Czechia, Sweden +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 1/1b Study of BMS-986463 in Advanced Malignant Tumors

France, Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Phase I/IIa, first-in-human, open-label, dose escalation trial with expansion cohorts to evaluate safety and preliminary efficacy of CLDN6 CAR-T with or without CLDN6 RNA-LPX in patients with CLDN6-positive relapsed or refractory advanced solid tumors

Sweden, Germany, Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Phase 1 First-In-Human Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors

France, Germany, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Uterine Cancer trials by city

Uterine Cancer in Toronto Uterine Cancer in Vancouver Uterine Cancer in Montreal Uterine Cancer in Calgary Uterine Cancer in Edmonton Uterine Cancer in Ottawa Uterine Cancer in Winnipeg Uterine Cancer in Quebec City Uterine Cancer in Hamilton Uterine Cancer in Kitchener Uterine Cancer in London Uterine Cancer in Halifax Uterine Cancer in New York Uterine Cancer in Los Angeles Uterine Cancer in Chicago Uterine Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease